Concept
Background of patients in Famotidine retrospective cohort study and Famotidine dosage
- Ten people who were diagnosed with COVID-19 and self-medicated with high doses of oral Famotidine participated in this study
- Seven patients tested positive for SARS-CoV-2 from nasal swabs, two patients had positive serological tests for COVID-19 antibodies and one had a clinical diagnosis without molecular confirmation
- Most common dose of Famotidine was 80 mg three time daily
- Overall, the does of Famotidine ranged from 20 mg to 80 mg and was self- administered orally three times a day
- Median duration of taking the drug was 11 days, while the range was 5-21 days
- Time period between onset of symptoms and taking Famotidine differed greatly between patients, ranging from 2 days to 26 days
0
1
Updated 2020-08-13
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences